David Weill's most recent trade in Transmedics Group Inc was a trade of 2,134 Common Stock done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 2,134 | 12,866 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 123.88 per share. | 22 May 2025 | 732 | 12,134 (0%) | 0% | 123.9 | 90,680 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 141.65 per share. | 29 May 2024 | 1,193 | 10,732 (0%) | 0% | 141.6 | 168,988 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,154 | 1,154 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 732 | 11,925 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 129.82 per share. | 10 May 2024 | 2,500 | 11,193 (0%) | 0% | 129.8 | 324,550 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Purchase of securities on an exchange or from another person at price $ 62.00 per share. | 29 Aug 2023 | 2,500 | 13,693 (0%) | 0% | 62 | 155,000 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,916 | 1,916 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,193 | 11,193 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | David Weill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.20 per share. | 27 Feb 2023 | 5,934 | 15,934 (0%) | 0% | 14.2 | 84,263 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 5,934 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 76.51 per share. | 27 Feb 2023 | 4,970 | 10,000 (0%) | 0% | 76.5 | 380,255 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 77.64 per share. | 27 Feb 2023 | 964 | 14,970 (0%) | 0% | 77.6 | 74,845 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Sale of securities on an exchange or to another person at price $ 56.00 per share. | 10 Nov 2022 | 21,645 | 13,500 (0%) | 0% | 56 | 1,212,120 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 10 Nov 2022 | 21,645 | 35,145 (0%) | 0% | 16 | 346,320 | Common Stock |
| Transmedics Group Inc | David Weill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 21,645 | 0 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | David Weill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) |